Skip to contentR
Rigel Pharmaceuticals Inc
R
RIGLRigel Pharmaceuticals Inc Released Nov 5, 2013, before the open
10-Q filed Nov 5, 2013, 36 days after period end · 0001104659-13-080831
Q3 2013 · 10-Q
Revenue—
Net income—
EPS Diluted-$0.27-$0.27N/M vs Q3 2012 No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
N/M vs Q2 2013
Operating Income-$23,930,000N/M Operating Cash Flowderived-$20,743,000N/M Free Cash Flowderived-$20,871,000N/M ended Sep 30, 2013 · filed Nov 5, 2013 · 36 d after period end
4.0% from the close of Nov 4, 2013 to the close of Nov 5, 2013, the first after the release.
before the open$3.00$2.88 Oct 7Nov 5Dec 2